EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Evaluation of hydrazone and N -acylhydrazone derivatives of vitamin B6 and pyridine-4-carbaldehyde as potential drugs against Alzheimer’s disease

Marija Bartolić, Ana Matošević, Nikola Maraković, Valentina Bušić, Sunčica Roca, Dražen Vikić-Topić, Antonio Sabljić, Anita Bosak, Dajana Gašo-Sokač

Journal of Enzyme Inhibition and Medicinal Chemistry · 2024

DOI: 10.1080/14756366.2024.2431832 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Enzyme Inhibition and Medicinal Chemistry, 2024. Verfasst von Marija Bartolić und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Toxicology, Institute for Medical Research and Occupational Health, Zagreb, Croatia. Hauptthemen laut MEDLINE: Hydrazones, Alzheimer Disease, Vitamin B 6, Pyridines. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The growing prevalence of Alzheimer's disease calls for a drug that can simultaneously act towards several targets involved in the pathophysiology of the disease. In our study, we evaluated the potential of hydrazone and N-acylhydrazone derivatives of vitamin B6 and pyridine-4-carbaldehyde to be used as multi-target directed ligands targeting cholinergic system by inhibiting acetyl- and butyrylcholinesterase, lowering the accumulation of β-amyloid plaques by inhibiting both the β-secretase activity and amyloid self-aggregation, and maintaining the biometal balance by chelating certain biometals. Our results showed that all of the tested hydrazones were potent inhibitors of human cholinesterases with inhibition constants (Ki) in micromolar range able to lower the activity of β-secretase, inhibit amyloid aggregation, chelate biometals and act as antioxidants. Also, most of them were estimated to be able to cross the blood-brain barrier by passive transport and to be absorbed in human intestines as well as with moderate metabolic stability in liver microsomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrazonesAlzheimer DiseaseVitamin B 6PyridinesCholinesterase InhibitorsHumansMolecular StructureStructure-Activity RelationshipAcetylcholinesteraseButyrylcholinesteraseDose-Response Relationship, DrugAmyloid beta-PeptidesAntioxidants

Stichwörter der Autor:innen

BACE1N-acylhydrazoneamyloid self-aggregationchelationcholinesterase

Substanzen

HydrazonesVitamin B 6PyridinesCholinesterase InhibitorsAcetylcholinesteraseButyrylcholinesteraseAmyloid beta-PeptidesAntioxidants

Autor:innen und Institutionen

  • Division of Toxicology, Institute for Medical Research and Occupational Health, Zagreb, Croatia.
  • Faculty of Food and Technology Osijek, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia.
  • NMR Centre, Rudjer Bošković Institute, Zagreb, Croatia.
  • Department of Natural and Health Sciences, Juraj Dobrila University of Pula, Pula, Croatia.

Zitieren

APA

Bartolić, M., Matošević, A., Maraković, N., Bušić, V., Roca, S., Vikić-Topić, D., Sabljić, A., Bosak, A., & Gašo-Sokač, D. (2024). Evaluation of hydrazone and N -acylhydrazone derivatives of vitamin B6 and pyridine-4-carbaldehyde as potential drugs against Alzheimer’s disease. Journal of Enzyme Inhibition and Medicinal Chemistry. https://doi.org/10.1080/14756366.2024.2431832

Vancouver

Bartolić M, Matošević A, Maraković N, Bušić V, Roca S, Vikić-Topić D, et al. Evaluation of hydrazone and N -acylhydrazone derivatives of vitamin B6 and pyridine-4-carbaldehyde as potential drugs against Alzheimer’s disease. Journal of Enzyme Inhibition and Medicinal Chemistry. 2024. doi:10.1080/14756366.2024.2431832

BibTeX
@article{Bartoli2024,
  author = {Bartolić, Marija and Matošević, Ana and Maraković, Nikola and Bušić, Valentina and Roca, Sunčica and Vikić-Topić, Dražen and Sabljić, Antonio and Bosak, Anita and Gašo-Sokač, Dajana},
  title = {Evaluation of hydrazone and N -acylhydrazone derivatives of vitamin B6 and pyridine-4-carbaldehyde as potential drugs against Alzheimer’s disease},
  journal = {Journal of Enzyme Inhibition and Medicinal Chemistry},
  year = {2024},
  doi = {10.1080/14756366.2024.2431832}
}
Kostenlos starten →